The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma
about
Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung CancerLong Non-coding RNAs and Their Roles in Non-small-cell Lung CancerLong non-coding RNAs in anti-cancer drug resistanceGenomic-Wide Analysis with Microarrays in Human OncologyExpression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb PathwayThe long noncoding RNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells.Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells.Notch-1 promotes breast cancer cells proliferation by regulating LncRNA GAS5The aspirin-induced long non-coding RNA OLA1P2 blocks phosphorylated STAT3 homodimer formation.High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapyNEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells.Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.Long non-coding RNA stabilizes the Y-box-binding protein 1 and regulates the epidermal growth factor receptor to promote lung carcinogenesis.Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.Long noncoding RNAs in lung cancer: what we know in 2015.Autophagy regulated by lncRNA HOTAIR contributes to the cisplatin-induced resistance in endometrial cancer cells.Perspectives of long non-coding RNAs in cancer.Role of long non-coding RNA in tumor drug resistance.Long noncoding and circular RNAs in lung cancer: advances and perspectives.Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/β-catenin pathwayLong non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in non-small cell lung cancer cells.Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response.TGFβ1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer.LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21.Overexpression of lncRNA NEAT1 mitigates multidrug resistance by inhibiting ABCG2 in leukemiaIntegrated analysis profiles of long non-coding RNAs reveal potential biomarkers of drug resistance in lung cancer.Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients.Potential applications of MEG3 in cancer diagnosis and prognosis.Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis.Gemcitabine treatment causes resistance and malignancy of pancreatic cancer stem-like cells via induction of lncRNA HOTAIR.LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer.Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy.DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer.Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma.MEG3 inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells.Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a.
P2860
Q26743378-01336908-39AF-4F25-A77E-F9775A2A23E2Q26743412-7EDEE164-2335-4710-9C6C-27AE994B169CQ28072366-4CC56FC6-340B-415C-ADD7-740FD87B6368Q28081059-8BB90DA7-37E4-4E12-8244-3B82EA679621Q28553467-BCDA7D2C-22F9-4DF7-85B3-12B505AEAA63Q33889127-E1F19A67-D6F3-4E42-AF90-03A9BD233A36Q33893229-4CA35217-4C2D-4C05-9E7E-33AD659F5604Q36183688-89B4EFC0-24DE-4C16-B090-65C6C0205E4EQ36603129-05C8521D-A20A-45E0-8129-778F7B6E3AB8Q37418043-FDB07DC2-289D-4341-9E45-E2E5655DC934Q37536566-FB20CD3D-1D75-4F02-9D83-AA745A0D4683Q37597116-D123218C-3AC9-4F00-AF6B-D6BEECECB23DQ37644894-A9B8D948-A7F3-4CEE-A7F7-5146A402930AQ37744782-50B217FA-E6CD-47FC-A3B9-B700F6E194DEQ38546133-483A588D-AD48-4812-85C9-2849255BC774Q38672942-717ED86D-DB70-444B-ACAA-9AB268EB8C70Q38696862-C1A0205A-BF7C-4162-8B6A-C455EBF06DB5Q38732979-A4CA39B9-647F-4013-917B-B1556F77568CQ38886641-53849630-70BD-4E92-A27A-5E78CE708A28Q38944003-65559EAD-83BF-4E94-A051-BFEFEC7DB3C5Q39652903-C5B85FBB-4770-43CA-9657-EC2D1F16BD1DQ40104790-FDCBAB6E-5183-4A51-A66B-752B505DEE4CQ40414194-662619A3-4E4B-4558-A950-7BE3CB572E0CQ41466279-76899E0F-8932-4217-92E4-31F8689AF168Q41481557-2123C7C9-DB11-48B1-B77E-FA4328E8A54EQ41498465-5694BE8F-2C6E-4C62-9C58-09D3179B8946Q41827476-F25D1B79-E92C-4C26-89F3-9C7FA1729C59Q41846396-AFE1F91B-4CBC-4C22-8946-17D34530210EQ42366529-34491D1F-1D48-4254-8457-E13B865A67DAQ42700665-41B41DBD-EEB4-4B0B-8C18-0C0BFEB20E27Q45287349-44CD2EB3-D57E-4AD1-A9B5-0558FE1B9FE2Q47134555-4BBF4B0B-1B87-42ED-BD18-733769B35F5FQ47138375-E5397777-3EF3-46E3-BF12-D60B0A1BE2BDQ47159016-150E2891-7189-44DF-9B8C-E12B869D1B08Q47411144-F98A7351-9CBB-4889-BBAA-B077377F0A6AQ47830977-29006A8A-8DED-4F6D-B6E1-B073B14D8499Q47906048-AAD6EEEC-53E6-4191-AFA4-2031FD98517EQ48346788-54D95258-9A24-4EF6-9550-440E8CA9F696Q49419404-9E17976B-60A2-4F36-A5CD-094FBCE2B79AQ49787300-0645258F-3A91-44BD-B2BA-2C1083E991C9
P2860
The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The Long Noncoding RNA MEG3 Co ...... e of Human Lung Adenocarcinoma
@ast
The Long Noncoding RNA MEG3 Co ...... e of Human Lung Adenocarcinoma
@en
The Long Noncoding RNA MEG3 Co ...... e of Human Lung Adenocarcinoma
@nl
type
label
The Long Noncoding RNA MEG3 Co ...... e of Human Lung Adenocarcinoma
@ast
The Long Noncoding RNA MEG3 Co ...... e of Human Lung Adenocarcinoma
@en
The Long Noncoding RNA MEG3 Co ...... e of Human Lung Adenocarcinoma
@nl
prefLabel
The Long Noncoding RNA MEG3 Co ...... e of Human Lung Adenocarcinoma
@ast
The Long Noncoding RNA MEG3 Co ...... e of Human Lung Adenocarcinoma
@en
The Long Noncoding RNA MEG3 Co ...... e of Human Lung Adenocarcinoma
@nl
P2093
P2860
P3181
P1433
P1476
The Long Noncoding RNA MEG3 Co ...... e of Human Lung Adenocarcinoma
@en
P2093
Guojian Liu
Ping Zhang
Zhaoxia Wang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0114586
P407
P577
2015-01-01T00:00:00Z